1. Home
  2. UNTY vs RGNX Comparison

UNTY vs RGNX Comparison

Compare UNTY & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$55.14

Market Cap

507.4M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$14.01

Market Cap

661.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
RGNX
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.4M
661.2M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
UNTY
RGNX
Price
$55.14
$14.01
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$59.67
$30.29
AVG Volume (30 Days)
35.0K
611.1K
Earning Date
01-14-2026
11-06-2025
Dividend Yield
1.09%
N/A
EPS Growth
35.12
N/A
EPS
5.27
N/A
Revenue
$121,970,000.00
$161,318,000.00
Revenue This Year
$24.41
$132.80
Revenue Next Year
$11.16
$48.47
P/E Ratio
$10.48
N/A
Revenue Growth
20.98
91.30
52 Week Low
$36.65
$5.04
52 Week High
$56.00
$14.24

Technical Indicators

Market Signals
Indicator
UNTY
RGNX
Relative Strength Index (RSI) 76.84 64.61
Support Level $51.25 $12.61
Resistance Level $56.00 $13.42
Average True Range (ATR) 1.72 0.84
MACD 0.51 0.08
Stochastic Oscillator 88.44 92.59

Price Performance

Historical Comparison
UNTY
RGNX

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: